ATRA CIK: 1604464

Atara Biotherapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−221
FY22:
−270
FY23:
−193
FY24:
−68.7
FY25:
−50.9
Change from FY21 to FY25
millions USD
FY21:
22.3
FY22:
203
FY23:
124
FY24:
8.62
FY25:
18.1
Change from FY21 to FY25
millions USD
FY21:
104
FY22:
53.1
FY23:
2.01
FY24:
59.3
FY25:
16.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−231
FY22:
−275
FY23:
−194
FY24:
−69.0
FY25:
−50.9

All amounts in millions USD Data source:SEC EDGAR